Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: Pros and cons

Arthritis Care and Research

Volumn 65, Issue 5, 2013, Pages 686-694

  Wildi, Lukas Martin ^a   Martel Pelletier, Johanne ^a   Abram, François ^b   Moser, Thomas ^a   Raynauld, Jean Pierre ^a   Pelletier, Jean Pierre ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LICOFELONE; NAPROXEN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; FEMALE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PUBLICATION; TREATMENT RESPONSE;

AGED; ANTIRHEUMATIC AGENTS; CARTILAGE, ARTICULAR; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84876699324     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21890     Document Type: Article

References (40)

1. Buckland-Wright JC, Ward RJ, Peterfy C, Mojcik CF, Leff RL,. Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis. J Rheumatol 2004; 31: 1588-97.
2. Guermazi A, Burstein D, Conaghan P, Eckstein F, Hellio Le Graverand-Gastineau MP, Keen H, et al. Imaging in osteoarthritis. Rheum Dis Clin North Am 2008; 34: 645-87.
3. Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004; 12: 177-90.
4. Kornaat PR, Ceulemans RY, Kroon HM, Riyazi N, Kloppenburg M, Carter WO, et al. MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS)-inter-observer and intra-observer reproducibility of a compartment-based scoring system. Skeletal Radiol 2005; 34: 95-102.
5. Hunter DJ, Lo GH, Gale D, Grainger AJ, Guermazi A, Conaghan PG,. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008; 67: 206-11.
6. Lynch JA, Roemer FW, Nevitt MC, Felson DT, Niu J, Eaton CB, et al. Comparison of BLOKS and WORMS scoring systems part I. Cross sectional comparison of methods to assess cartilage morphology, meniscal damage and bone marrow lesions on knee MRI: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2010; 18: 1393-401.
7. Felson DT, Lynch J, Guermazi A, Roemer FW, Niu J, McAlindon T, et al. Comparison of BLOKS and WORMS scoring systems part II. Longitudinal assessment of knee MRIs for osteoarthritis and suggested approach based on their performance: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2010; 18: 1402-7.
8. Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G,. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage 2005; 13: 198-205.
9. Hunter DJ, Guermazi A, Lo GH, Grainger AJ, Conaghan PG, Boudreau RM, et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis Cartilage 2011; 19: 990-1002.
10. Kauffmann C, Gravel P, Godbout B, Gravel A, Beaudoin G, Raynauld JP, et al. Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model. IEEE Trans Biomed Eng 2003; 50: 978-88.
11. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Labonte F, Beaudoin G, de Guise JA, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004; 50: 476-87.
12. Eckstein F, Cicuttini F, Raynauld JP, Waterton JC, Peterfy C,. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006; 14: A46-75.
13. Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 2009; 68: 938-47.
14. Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011; 70: 982-9.
15. Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Choquette D, et al. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum 2010; 40: 185-92.
16. Peterfy CG, Gold G, Eckstein F, Cicuttini F, Dardzinski B, Stevens R,. MRI protocols for whole-organ assessment of the knee in osteoarthritis. Osteoarthritis Cartilage 2006; 14 Suppl: A95-111.
17. Roemer FW, Kwoh CK, Hannon MJ, Crema MD, Moore CE, Jakicic JM, et al. Semiquantitative assessment of focal cartilage damage at 3T MRI: a comparative study of dual echo at steady state (DESS) and intermediate-weighted (IW) fat suppressed fast spin echo sequences. Eur J Radiol 2011; 80: 126-31.
18. Mohr A,. The value of water-excitation 3D FLASH and fat-saturated PDw TSE MR imaging for detecting and grading articular cartilage lesions of the knee. Skeletal Radiol 2003; 32: 396-402.
19. Stahl R, Luke A, Ma CB, Krug R, Steinbach L, Majumdar S, et al. Prevalence of pathologic findings in asymptomatic knees of marathon runners before and after a competition in comparison with physically active subjects: a 3.0 T magnetic resonance imaging study. Skeletal Radiol 2008; 37: 627-38.
20. Hayashi D, Roemer FW, Guermazi A,. Choice of pulse sequences for magnetic resonance imaging-based semiquantitative assessment of cartilage defects in osteoarthritis research: comment on the article by Doré et al [letter]. Arthritis Rheum 2010; 62: 3830-1.
21. Dore D, Winzenberg T, Ding C, Cicuttini F, Jones G,. Reply [letter]. Arthritis Rheum 2010; 62: 381-2.
22. Masi JN, Sell CA, Phan C, Han E, Newitt D, Steinbach L, et al. Cartilage MR imaging at 3.0 versus that at 1.5 T: preliminary results in a porcine model. Radiology 2005; 236: 140-50.
23. Yoshioka H, Stevens K, Hargreaves BA, Steines D, Genovese M, Dillingham MF, et al. Magnetic resonance imaging of articular cartilage of the knee: comparison between fat-suppressed three-dimensional SPGR imaging, fat-suppressed FSE imaging, and fat-suppressed three-dimensional DEFT imaging, and correlation with arthroscopy. J Magn Reson Imaging 2004; 20: 857-64.
24. Lee SY, Jee WH, Kim SK, Koh IJ, Kim JM,. Differentiation between grade 3 and grade 4 articular cartilage defects of the knee: fat-suppressed proton density-weighted versus fat-suppressed three-dimensional gradient-echo MRI. Acta Radiol 2010; 51: 455-61.
25. Bauer JS, Barr C, Henning TD, Malfair D, Ma CB, Steinbach L, et al. Magnetic resonance imaging of the ankle at 3.0 Tesla and 1.5 Tesla in human cadaver specimens with artificially created lesions of cartilage and ligaments. Invest Radiol 2008; 43: 604-11.
26. Cooper C, Reginster JY, Chapurlat R, Christiansen C, Genant H, Bellamy N, et al. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Curr Med Res Opin 2012; 28: 231-9.
27. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
28. Wildi LM, Raynauld JP, Martel-Pelletier J, Abram F, Dorais M, Pelletier JP,. Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI. Ann Rheum Dis 2010; 69: 2118-24.
29. Raynauld JP, Martel-Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi LM, et al. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 2011; 70: 1382-8.
30. Eckstein F, Hudelmaier M, Wirth W, Kiefer B, Jackson R, Yu J, et al. Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis 2006; 65: 433-41.
31. Raynauld JP, Kauffmann C, Beaudoin G, Berthiaume MJ, de Guise JA, Bloch DA, et al. Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthritis Cartilage 2003; 11: 351-60.
32. Raynauld JP, Martel-Pelletier J, Abram F, Dorais M, Haraoui B, Choquette D, et al. Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis. Arthritis Res Ther 2008; 10: R129.
33. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Beaudoin G, Choquette D, Haraoui B, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 2006; 8: R21.
34. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
35. Hudelmaier M, Wirth W, Wehr B, Kraus V, Wyman BT, Hellio Le Graverand MP, et al. Femorotibial cartilage morphology: reproducibility of different metrics and femoral regions, and sensitivity to change in disease. Cells Tissues Organs 2010; 192: 340-50.
36. Conrozier T, Brandt K, Piperno M, Mathieu P, Merle-Vincent F, Vignon E,. Reproducibility and sensitivity to change of a new method of computer measurement of joint space width in hip osteoarthritis: performance of three radiographic views obtained at a 3-year interval. Osteoarthritis Cartilage 2009; 17: 864-70.
37. Stratford PW, Riddle DL,. Assessing sensitivity to change: choosing the appropriate change coefficient. Health Qual Life Outcomes 2005; 3: 23.
38. Hayashi D, Guermazi A, Hunter DJ,. Osteoarthritis year 2010 in review: imaging. Osteoarthritis Cartilage 2011; 19: 354-60.
39. Stahl R, Jain SK, Lutz J, Wyman BT, Le Graverand-Gastineau MP, Vignon E, et al. Osteoarthritis of the knee at 3.0 T: comparison of a quantitative and a semi-quantitative score for the assessment of the extent of cartilage lesion and bone marrow edema pattern in a 24-month longitudinal study. Skeletal Radiol 2011; 40: 1315-27.
40. Middel B, van Sonderen E,. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care 2002; 2: e15.